PlainRecalls
FDA Drug Moderate Class II Terminated

Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01

Reported: November 4, 2020 Initiated: October 5, 2020 #D-0053-2021

Product Description

Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01

Reason for Recall

An extraneous peak was observed for dissolution testing.

Details

Units Affected
N/A
Distribution
Distributed Nationwide in the USA and Puerto Rico
Location
Ridgefield, CT

Frequently Asked Questions

What product was recalled?
Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01. Recalled by Boehringer Ingelheim Pharmaceuticals, Inc.. Units affected: N/A.
Why was this product recalled?
An extraneous peak was observed for dissolution testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 4, 2020. Severity: Moderate. Recall number: D-0053-2021.